Etoricoxib D4 blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.
Molecular Weight
362.87
Molecular Formula
C18H11D4ClN2O2S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Etoricoxib D4 is a deuterated form of Etoricoxib used to study COX-2 inhibition and anti-inflammatory effects with improved pharmacokinetic properties.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.